Trends in Treatment and Survival of Gallbladder Cancer in the Netherlands; Identifying Gaps and Opportunities from a Nation-Wide Cohort.
chemotherapy
cohort studies
epidemiology
gallbladder neoplasms
surgery
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
09 Apr 2020
09 Apr 2020
Historique:
received:
09
03
2020
revised:
31
03
2020
accepted:
03
04
2020
entrez:
15
4
2020
pubmed:
15
4
2020
medline:
15
4
2020
Statut:
epublish
Résumé
Gallbladder cancer (GBC) is rare in Western populations and data about treatment and outcomes are scarce. This study aims to analyze survival and identify opportunities for improvement using population-based data from a low-incidence country. GBC patients diagnosed between 2005 and 2016 with GBC were identified from the Netherlands Cancer Registry. Patients were grouped according to time period (2005-2009/2010-2016) and disease stage. Trends in treatment and overall survival (OS) were analyzed. In total 1834 patients were included: 661 (36%) patients with resected, 278 (15%) with non-resected non-metastatic, and 895 (49%) with metastatic GBC. Use of radical versus simple cholecystectomy (12% vs. 26%,
Identifiants
pubmed: 32283627
pii: cancers12040918
doi: 10.3390/cancers12040918
pmc: PMC7226578
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : ADP
ID : 55695817
Références
Ann Surg. 2000 Oct;232(4):557-69
pubmed: 10998654
J Surg Oncol. 2017 Apr;115(5):580-590
pubmed: 28138977
Br J Cancer. 2007 May 7;96(9):1457-61
pubmed: 17375043
Clin Epidemiol. 2014 Mar 07;6:99-109
pubmed: 24634588
Ann Surg Oncol. 2007 Feb;14(2):833-40
pubmed: 17103074
Cancer Discov. 2017 Sep;7(9):943-962
pubmed: 28818953
World J Gastroenterol. 2015 Apr 21;21(15):4620-6
pubmed: 25914471
Ann Surg. 1994 Mar;219(3):275-80
pubmed: 8147608
Ann Surg Oncol. 2016 Dec;23(13):4401-4409
pubmed: 27495279
Int J Epidemiol. 1993 Jun;22(3):369-76
pubmed: 8359950
J Clin Oncol. 2019 Mar 10;37(8):658-667
pubmed: 30707660
HPB (Oxford). 2013 Aug;15(8):633-7
pubmed: 23458168
Dig Surg. 2012;29(2):92-8
pubmed: 22441693
J Am Coll Surg. 2008 Sep;207(3):371-82
pubmed: 18722943
Surg Gynecol Obstet. 1978 Dec;147(6):929-42
pubmed: 362580
N Engl J Med. 2010 Apr 8;362(14):1273-81
pubmed: 20375404
Ann Surg. 1996 Nov;224(5):639-46
pubmed: 8916879
J Surg Oncol. 2008 Dec 1;98(7):485-9
pubmed: 18802958
Cancer Imaging. 2014 Apr 22;14:14
pubmed: 25608662
Eur J Surg Oncol. 2017 Apr;43(4):763-771
pubmed: 28100416
Surg Endosc. 2008 Nov;22(11):2462-5
pubmed: 18247090
Ann Surg Oncol. 2009 Aug;16(8):2101-15
pubmed: 19495882
Cell Oncol. 2007;29(1):19-24
pubmed: 17429138
HPB (Oxford). 2013 Jan;15(1):40-8
pubmed: 23216778
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Lancet Oncol. 2019 May;20(5):663-673
pubmed: 30922733
J Gastrointest Surg. 2013 May;17(5):925-30
pubmed: 23299221
Br J Cancer. 2009 Jan 13;100(1):194-9
pubmed: 19034278
Cancer. 2016 Dec 15;122(24):3838-3847
pubmed: 27622582
Int J Surg. 2018 May;53:178-183
pubmed: 29602013
J Gastrointest Oncol. 2017 Apr;8(2):293-301
pubmed: 28480068
Aliment Pharmacol Ther. 2011 Nov;34(9):1063-78
pubmed: 21933219
World J Gastroenterol. 2011 Jan 14;17(2):174-80
pubmed: 21245989